Biotypes and antimicrobial susceptibilities of Brucella isolates

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 5, 2003, Pages 337-338

  Bodur, Hürrem ^a   Balaban, Neriman ^a   Aksaray, Sebahat ^a   Yetener, Vedat ^a   Akinci, Esragül ^a   Çolpan, Aylin ^a   Erbay, Ayse ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOTYPE; BLOOD CULTURE; BRUCELLA MELITENSIS; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BRUCELLA MELITENSIS; BRUCELLOSIS; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TURKEY;

EID: 0038455751     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310008348     Document Type: Article

References (11)

1. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone; 2000. p. 2386-90.
2. Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory Paris: INRA; 1988.
3. Morey NP, Holcomb LA. Brucella. In: Murray PR, Baron EJ, Pfaaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington, DC: ASM Press; 1995. p. 549-55.
4. Garcia-Rodriguez JA, Garcia Sanchez JE, Trujillano I. Lack of effective bacterial activity of new quinolones against Brucella spp. Antimicrob Agents Chemother 1991; 35: 756-9.
5. Gür D, Kocagöz S, Akova M, Ünal S. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrob Agents Chemother 1999; 43: 2337.
6. Rubinstein ER, Lang R, Shasha B, Hagar B, Diamanstein L, Joseph G, et al. In vitro susceptibility of Brucella melitensis to antibiotics. Antimicrob Agents Chemother 1991; 35: 1925-7.
7. Trujillano-Martin I, Garcia-Sanchez E, Martinez IM, Fresnadillo MJ, Garcia-Sanchez JE, Garcia-Rodriguez JA, et al. In vitro activities of six new fluoroquinolones against Brucella melitensis. Antimicrob Agents Chemother 1999; 43: 194-5.
8. Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother 1999; 43: 1298-300.
9. Kocagöz S, Akova M, Altun B, Gür D, Hasçelik G. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect 2002; 8: 240-2.
10. Kinsara A, Al-Mowallad A, Osaba AO. Increasing resistance of Brucellae to co-trimoxazole. Antimicrob Agents Chemother 1999; 43: 1531.
11. Qadri SM, Akhtar M, Ueno Y, al-Sabia MB. Susceptibility of Brucella melitensis to fluoroquinolones. Drugs Exp Clin Res 1989; 15: 483-5.